Sheba signs ‘breakthrough’ deal to give diabetic care in UAE

The service will be provided by Sheba’s Institute of Endocrinology unit, headed by Dr.Amir Tirosh, using the Datos Health remote patient management application.

From left (front row) Yoel Hareven and Abdullah Saeed Al Naboodah; from left (back row) Galia Barkai, Marwan Ibrahim Haji Nasser, Keren Yaniv and Bruce Gurfein. (photo credit: Courtesy)
From left (front row) Yoel Hareven and Abdullah Saeed Al Naboodah; from left (back row) Galia Barkai, Marwan Ibrahim Haji Nasser, Keren Yaniv and Bruce Gurfein.
(photo credit: Courtesy)
Sheba Medical Center at Tel Hashomer has signed a “breakthrough” agreement to provide treatment to diabetics in Dubai, The Jerusalem Post has confirmed.
The deal, the first of its kind signed under the “Sheba BEYOND” program, was clinched on Monday in Dubai with the Al Tadawi Healthcare group. The medical centers had agreed on a partnership back in December 2020.
Al Tadawi Medical Center will now be providing its diabetic patients with treatment onsite through visits by top Sheba endocrinologists, as well as by remote monitoring via the Datos Health management application.
The new program will be called the Sheba Al Tadawi Diabetic Clinic in Dubai and the service will be provided by Sheba’s Institute of Endocrinology, headed by Dr. Amir Tirosh.
Monday’s kick-off event was attended by Yoel Hareven, director of the International Division & Resource Development at Sheba; Abdullah Saeed Al Naboodah,  Chairman of Al Naboodah Investments Company; Galia Barkai, director of Sheba BEYOND - the first virtual Hospital at Sheba; Marwan Ibrahim Haji Nasser, chairman and managing director of the Al Tadawi Healthcare Group; Keren Yaniv, head of International Marketing for Sheba; and Bruce Gurfein of the Phoenix Group.
“Rarely is there an opportunity to take part in a breakthrough,” Barkai wrote in a Facebook post. “This is just the beginning.”